OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
Ajaz A. Bhat, Sabah Nisar, Selma Maacha, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 109

Showing 26-50 of 109 citing articles:

Designing a CXCL8-hsa chimera as potential immunmodulator of the tumor micro-environment
Tanja Gerlza, Christina Trojacher, Thomas J. Fuchs, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Characterizing macrophage diversity in colorectal malignancies through single-cell genomics
Tianjing Zhao, Yinyi Luo, Yuanjie Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access

Molecularly Imprinted Polymer Advanced Hydrogels as Tools for Gastrointestinal Diagnostics
Tatjana Ivaškienė, Greta Kaspute, Arūnas Ramanavičius, et al.
Gels (2025) Vol. 11, Iss. 4, pp. 269-269
Open Access

Targeting the Microenvironment in Esophageal Cancer
Lei Wang, Huiqiong Han, Zehua Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24

Roles of CCR10/CCL27–CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives
Ermias Mergia Terefe, Maria Jade Catalan Opulencia, Amir Rakhshani, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Closed Access | Times Cited: 16

A1 adenosine receptor antagonist induces cell apoptosis in KYSE-30 and YM-1 esophageal cancer cell lines
Parisa Zeynali, Marie Saghaeian Jazi, Jahanbakhsh Asadi, et al.
Biomedicine (2023) Vol. 13, Iss. 1, pp. 54-61
Open Access | Times Cited: 9

PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ flux
Shishuo Sun, Heng Xu, Wanxin Zhao, et al.
Cancer Letters (2023) Vol. 581, pp. 216511-216511
Closed Access | Times Cited: 9

Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116873-116873
Open Access | Times Cited: 3

Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy
Haebeen Jung, Silke Paust
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Unlocking the Secrets of Extracellular Vesicles: Orchestrating Tumor Microenvironment Dynamics in Metastasis, Drug Resistance, and Immune Evasion
Rashid Mir, Sadaf Khursheed Baba, Imadeldin Elfaki, et al.
Journal of Cancer (2024) Vol. 15, Iss. 19, pp. 6383-6415
Open Access | Times Cited: 3

The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
Rathasapa Patarat, Shoji Riku, Pattapon Kunadirek, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22

Regulatory T cell-exosomal miR-142-3p promotes angiogenesis and osteogenesis via TGFBR1/SMAD2 inhibition to accelerate fracture repair
Lang Chen, Yuan Xiong, Yiqiang Hu, et al.
Chemical Engineering Journal (2021) Vol. 427, pp. 131419-131419
Open Access | Times Cited: 21

Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma
Wenqing Gao, Yuanyuan Li, Teng Zhang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 2731-2743
Open Access | Times Cited: 15

Synergistic Chemo-Photothermal and Ferroptosis Therapy of Polydopamine Nanoparticles for Esophageal Cancer
Yukun Chen, Mingliang Su, Lijun Jia, et al.
Nanomedicine (2022) Vol. 17, Iss. 16, pp. 1115-1130
Closed Access | Times Cited: 15

Single-Cell VEGF Analysis by Fluorescence Imaging–Microfluidic Droplet Platform: An Immunosandwich Strategy on the Cell Surface
Lili Cong, Yu Tian, Zepeng Huo, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 17, pp. 6591-6598
Closed Access | Times Cited: 14

Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma
Tao Fan, Yu Liu, Hengchang Liu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 12, pp. 3651-3667
Open Access | Times Cited: 20

miRNAs as novel immunoregulators in cancer
Saife N. Lone, Ajaz A. Bhat, Nissar Ahmad Wani, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 3-14
Closed Access | Times Cited: 18

Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights
Katherine M. Weh, Yun Zhang, Connor L. Howard, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 969-969
Open Access | Times Cited: 13

Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies
Alessio Ardizzone, Rossella Basilotta, Alessia Filippone, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 841-841
Open Access | Times Cited: 7

Scroll to top